Contact Us

Tysabri
*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 

Phone 

Cell Phone 

Street Address 

Zip Code 

City 

State 

Date you started taking this drug:

Date you stopped taking this drug:

Please describe side effects:

For verification purposes, please answer the below question:
+
=

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.


CORRECTION: MULTIPLE SCLEROSIS DRUG (TYSABRI) MAY HAVE BEEN RESPONSIBLE FOR FOURTH CASE OF RARE BRAIN DISEASE

Jun 4, 2005 | www.Newsinferno.com

Yesterday, we reported that the FDA had been informed by Biogen Idec Inc. that a fourth person may have died from a rare and often fatal brain disease known as progressive multifocal leukoencephalopathy (PML) after short-term treatment with its embattled multiple sclerosis drug Tysabri. Actually, that person remains alive and is currently being treated for the disease.


Related articles
Parker Waichman Accolades And Reviews Best Lawyers Find Us On Avvo